High vaccine coverage and non-pharmaceutical interventions decreased hospitalizations and deaths due to the Omicron variant in Newfoundland and Labrador, Canada
Authors:
Preprint
Abstract
The Canadian province of Newfoundland and Labrador (NL) had high vaccination coverage, and few infections were reported prior to the establishment of the Omicron variant. We investigated whether changes in the timing and rate of booster dose administration could have reduced severe disease outcome and reliance on non-pharmaceutical interventions (NPIs) during the Omicron wave in NL. We used a vaccination-stratified epidemiological model calibrated to serology data to investigate the impact of vaccination relative to counterfactual vaccination strategies under actual, strict and no NPI scenarios. Compared with a Canadian vaccination rate scenario, the actual vaccination rollout in NL was estimated to have prevented approximately 519 hospitalizations and 122 deaths from December 15, 2021 to December 15, 2022, corresponding to reductions of 25.9% and 30.9%, respectively. These reductions reflected contributions from NL’s higher initial primary series coverage (81.3%), higher final booster dose coverage (57.3%), and the implementation of various NPIs for 89 days after the Omicron BA.1 variant became established. Earlier and faster administration of booster doses reduced the duration of strict NPIs required to achieve hospitalization targets. Our findings show how the timing and rate of vaccination rollout can complement NPIs to reduce severe disease and the duration for which strict NPIs are required.Keywords
Funding Information
- Natural Sciences and Engineering Research Council of Canada (Discovery Grant (RGPIN-2023-05905))
- Canadian Network for Modelling Infectious Diseases (560516-2020)
This publication has 31 references indexed in Scilit:
- Changing contact patterns in Newfoundland and Labrador, Canada in response to public health measures during the COVID-19 pandemicEpidemics, 2026
- The effect of vaccine mandate announcements on vaccine uptake in Canada: An interrupted time series analysisVaccine, 2023
- Pandemic modelling for regions implementing an elimination strategyJournal of Theoretical Biology, 2022
- Estimated Effectiveness of COVID-19 Vaccines Against Omicron or Delta Symptomatic Infection and Severe OutcomesJAMA Network Open, 2022
- Pandemic fatigue or enduring precautionary behaviours? Canadians’ long-term response to COVID-19 public health measuresPreventive Medicine Reports, 2022
- COVID-19-Associated Hospitalizations Among Vaccinated and Unvaccinated Adults 18 Years or Older in 13 US States, January 2021 to April 2022JAMA Internal Medicine, 2022
- Evolution of the SARS‐CoV‐2 omicron variants BA.1 to BA.5: Implications for immune escape and transmissionReviews in Medical Virology, 2022
- Public health guideline compliance and perceived government effectiveness during the COVID-19 pandemic in Canada: Findings from a longitudinal cohort studyThe Lancet Regional Health - Americas, 2022
- Non-pharmaceutical interventions, vaccination, and the SARS-CoV-2 delta variant in England: a mathematical modelling studyThe Lancet, 2021
- Impact of COVID-19 on the social, economic, environmental and energy domains: Lessons learnt from a global pandemicSustainable Production and Consumption, 2021